Definitive Healthcare Corp. (NASDAQ:DH) Position Cut by Oppenheimer Asset Management Inc.

Posted by on May 6th, 2023

Oppenheimer Asset Management Inc. trimmed its stake in Definitive Healthcare Corp. (NASDAQ:DH – Get Rating) by 5.4% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 95,722 shares of the company’s stock after selling 5,481 shares during the quarter. Oppenheimer Asset Management Inc. owned approximately 0.09% of Definitive Healthcare worth $1,052,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Ensign Peak Advisors Inc bought a new stake in Definitive Healthcare in the third quarter valued at $53,000. Captrust Financial Advisors raised its stake in shares of Definitive Healthcare by 2,358.9% during the second quarter. Captrust Financial Advisors now owns 4,721 shares of the company’s stock valued at $108,000 after purchasing an additional 4,529 shares in the last quarter. US Bancorp DE raised its stake in shares of Definitive Healthcare by 81.0% during the first quarter. US Bancorp DE now owns 5,087 shares of the company’s stock valued at $125,000 after purchasing an additional 2,276 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank bought a new stake in shares of Definitive Healthcare during the third quarter valued at about $81,000. Finally, Steph & Co. raised its stake in shares of Definitive Healthcare by 35.5% during the fourth quarter. Steph & Co. now owns 5,619 shares of the company’s stock valued at $62,000 after purchasing an additional 1,471 shares in the last quarter.

Definitive Healthcare Trading Up 3.1 %

Shares of DH opened at $10.21 on Friday. The business’s 50-day moving average price is $10.87 and its 200 day moving average price is $11.79. The stock has a market capitalization of $1.12 billion, a P/E ratio of -102.09, a P/E/G ratio of 29.72 and a beta of 0.51. Definitive Healthcare Corp. has a 1-year low of $8.71 and a 1-year high of $30.11. The company has a current ratio of 3.12, a quick ratio of 3.12 and a debt-to-equity ratio of 0.17.

Definitive Healthcare (NASDAQ:DH – Get Rating) last issued its quarterly earnings results on Thursday, February 23rd. The company reported $0.01 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.02. The firm had revenue of $60.60 million for the quarter, compared to analysts’ expectations of $58.61 million. Definitive Healthcare had a positive return on equity of 0.35% and a negative net margin of 2.71%. Analysts expect that Definitive Healthcare Corp. will post 0.02 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the stock. Robert W. Baird cut their price objective on shares of Definitive Healthcare from $15.00 to $13.00 in a research note on Friday. Morgan Stanley cut their price objective on shares of Definitive Healthcare from $18.00 to $17.00 and set an “overweight” rating on the stock in a research note on Tuesday, February 28th. Credit Suisse Group cut their price objective on shares of Definitive Healthcare from $19.00 to $15.00 and set a “neutral” rating on the stock in a research note on Friday, February 24th. Needham & Company LLC reaffirmed a “buy” rating and set a $15.00 target price on shares of Definitive Healthcare in a report on Friday, February 24th. Finally, William Blair started coverage on Definitive Healthcare in a report on Wednesday, April 19th. They set an “outperform” rating on the stock. Four analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $15.43.

Definitive Healthcare Company Profile

(Get Rating)

Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution.

Recommended Stories

Institutional Ownership by Quarter for Definitive Healthcare (NASDAQ:DH)

Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.